Skip to main content
. 2009 Jan;174(1):330–342. doi: 10.2353/ajpath.2009.080385

Figure 6.

Figure 6

Effect of valproate supplementation on hepatic GSK-3 activity. GSK-3β was immunoprecipitated from protein lysates prepared from the livers of normoglycemic (control) and hyperglycemic (HG) mice fed control or valproate-supplemented diet. GSK-3β kinase activity was determined as previously described.10 n = 3, *P < 0.05 relative to nonsupplemented control. **P < 0.05 relative to nonsupplemented HG.